Home > > > > > Report Detail

Global Anticoagulants Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2022-2028

Publisher Name :
Date: 12-Sep-2022
No. of pages: 108
Inquire Before Buying

Anticoagulants, commonly referred to as blood thinners, are substances that prevent or reduce coagulation of blood, prolonging the clotting time. Some of them occur naturally in blood-eating animals such as leeches and mosquitoes, where they help keep the bite area unclotted long enough for the animal to obtain some blood. As a class of medications, anticoagulants are used in therapy for thrombotic disorders. Oral anticoagulants (OACs) are taken by many people in pill or tablet form, and various intravenous anticoagulant dosage forms are used in hospitals. Some anticoagulants are used in medical equipment, such as test tubes, serum-separating tubes, blood transfusion bags, and dialysis equipment.

Highlights

Considering the economic change due to COVID-19 and Russia-Ukraine War Influence, the global Anticoagulants market is projected to reach US$ 35930 million by 2028 from an estimated US$ 27270 million in 2022, at a CAGR of 4.7% during 2023 and 2028.

Market competition is intense. Sanofi, Bristol-Myers Squibb, Bayer, Johnson & Johnson, Genentech (Roche) and Boehringer Ingelheim etc. are the leaders of the industry, with about 64% market shares.

North America is the largest consumption place, with a consumption market share nearly 39%. Following North America, Europe is the second largest consumption place with the consumption market share of 26%.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Anticoagulants, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyse their position in the current marketplace, and make informed business decisions regarding Anticoagulants.

The Anticoagulants market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2021 as the base year, with history and forecast data for the period from 2017 to 2028. This report segments the global Anticoagulants market comprehensively. Regional market sizes, concerning products by type, by application, and by players, are also provided. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Anticoagulants companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, product type, application, and regions.

Key Companies & Market Share Insights

In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue by companies for the period 2017-2022. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses. Some of the prominent players reviewed in the research report include:

- Sanofi

- Bristol-Myers Squibb

- Bayer

- Johnson & Johnson.

- Genentech (Roche)

- Boehringer Ingelheim

- Lilly

- Daiichi Sankyo

- Otsuka

- AstraZeneca

- Pfizer

- Aspen

- The Medicines Company

Product Type Insights

Global markets are presented by Anticoagulants type, along with growth forecasts through 2028. Estimates on revenue are based on the price in the supply chain at which the Anticoagulants are procured by the companies.

This report has studied every segment and provided the market size using historical data. They have also talked about the growth opportunities that the segment may pose in the future. This study bestows revenue data by type, and during the historical period (2017-2022) and forecast period (2023-2028).

Anticoagulants Segment by Type

- Platelet Aggregation Inhibitors (PAI)

- Low-Molecular-Weight Heparin (LMWH)

- Direct Thrombin Inhibitor (DTI)

- Direct Factor Xa Inhibitors (DFXa)

- Vitamin K antagonists (VKA)

- Others

Application Insights

This report has provided the market size (revenue data) by application, during the historical period (2017-2022) and forecast period (2023-2028).

This report also outlines the market trends of each segment and consumer behaviors impacting the Anticoagulants market and what implications these may have on the industry's future. This report can help to understand the relevant market and consumer trends that are driving the Anticoagulants market.

Anticoagulants Segment by Application

- VTE

- ACS/MI

- AF

- Others

Regional Outlook

This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the revenue of each region and country for the period 2017-2028.

The market has been segmented into various major geographies, including North America, Europe, Asia-Pacific, South America, Middle East & Africa. Detailed analysis of major countries such as the USA, Germany, the U.K., Italy, France, China, Japan, South Korea, Southeast Asia, and India will be covered within the regional segment. For market estimates, data are going to be provided for 2021 because of the base year, with estimates for 2022 and forecast revenue for 2028.

- North America

- - United States

- - Canada

- Europe

- - Germany

- - France

- - U.K.

- - Italy

- - Russia

- - Nordic Countries

- - Benelux

- - Rest of Europe

- Asia-Pacific

- - China

- - Japan

- - South Korea

- - India

- - Southeast Asia

- - Australia

- - Rest of Asia-Pacific

- Latin America

- - Mexico

- - Brazil

- - Argentina

- - Rest of Latin America

- Middle East & Africa

- - Turkey

- - Saudi Arabia

- - UAE

- - Rest of Middle East & Africa

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

COVID-19 and Russia-Ukraine War Influence Analysis

The readers in the section will understand how the Anticoagulants market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.

Reasons to Buy This Report

This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Anticoagulants market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

This report will help stakeholders to understand the global industry status and trends of Anticoagulants and provides them with information on key market drivers, restraints, challenges, and opportunities.

This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.

This report stays updated with novel technology integration, features, and the latest developments in the market

This report helps stakeholders to understand the COVID-19 and Russia-Ukraine War Influence on the Anticoagulants industry.

This report helps stakeholders to gain insights into which regions to target globally.

This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Anticoagulants.

This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Global Anticoagulants Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2022-2028

Table of Contents
1 Study Coverage
1.1 Anticoagulants Product Introduction
1.2 Market by Type
1.2.1 Global Anticoagulants Market Size Growth Rate by Type (2017 VS 2021 VS 2028)
1.2.2 Platelet Aggregation Inhibitors (PAI)
1.2.3 Low-Molecular-Weight Heparin (LMWH)
1.2.4 Direct Thrombin Inhibitor (DTI)
1.2.5 Direct Factor Xa Inhibitors (DFXa)
1.2.6 Vitamin K antagonists (VKA)
1.2.7 Others
1.3 Market by Application
1.3.1 Global Anticoagulants Market Size Growth Rate by Application (2017 VS 2021 VS 2028)
1.3.2 VTE
1.3.3 ACS/MI
1.3.4 AF
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Anticoagulants Market Size Estimates and Forecasts
2.2 Anticoagulants Market Size by Region: 2022 Versus 2028
2.2.1 Global Anticoagulants Revenue by Region: 2017-2022
2.2.2 Global Anticoagulants Revenue Forecast by Region (2023-2028)
2.2.3 Global Anticoagulants Revenue Market Share by Region (2017-2028)
3 Global Anticoagulants by Company
3.1 Global Anticoagulants Revenue by Company (2017-2022)
3.2 Global Anticoagulants Revenue Share by Company (2017-2022)
3.3 Competitive Landscape
3.3.1 Key Anticoagulants Companies around the World: Ranking by Revenue
3.3.2 Global Anticoagulants Market Concentration Ratio (CR5 and HHI) & (2017-2022)
3.3.3 Global Anticoagulants Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.4 Global Anticoagulants Companies Headquarters & Product Type
3.4.1 Anticoagulants Companies Headquarters
3.4.2 Global Anticoagulants Companies Product & Service
3.4.3 Date of International Companies Enter into Anticoagulants Market
3.5 Global Anticoagulants Mergers & Acquisitions, Expansion Plans
4 Company Profiles
4.1 Sanofi
4.1.1 Sanofi Corporation Information
4.1.2 Sanofi Description, Business Overview
4.1.3 Sanofi Anticoagulants Products Offered
4.1.4 Sanofi Anticoagulants Revenue and Gross Margin (2017-2022)
4.1.5 Sanofi Anticoagulants Revenue by Product in 2021
4.1.6 Sanofi Anticoagulants Revenue by Application in 2021
4.1.7 Sanofi Anticoagulants Revenue by Geographic Area in 2021
4.1.8 Sanofi Recent Developments
4.2 Bristol-Myers Squibb
4.2.1 Bristol-Myers Squibb Corporation Information
4.2.2 Bristol-Myers Squibb Description, Business Overview
4.2.3 Bristol-Myers Squibb Anticoagulants Products Offered
4.2.4 Bristol-Myers Squibb Anticoagulants Revenue and Gross Margin (2017-2022)
4.2.5 Bristol-Myers Squibb Anticoagulants Revenue by Product in 2021
4.2.6 Bristol-Myers Squibb Anticoagulants Revenue by Application in 2021
4.2.7 Bristol-Myers Squibb Anticoagulants Revenue by Geographic Area in 2021
4.2.8 Bristol-Myers Squibb Recent Developments
4.3 Bayer
4.3.1 Bayer Corporation Information
4.3.2 Bayer Description, Business Overview
4.3.3 Bayer Anticoagulants Products Offered
4.3.4 Bayer Anticoagulants Revenue and Gross Margin (2017-2022)
4.3.5 Bayer Anticoagulants Revenue by Product in 2021
4.3.6 Bayer Anticoagulants Revenue by Application in 2021
4.3.7 Bayer Anticoagulants Revenue by Geographic Area in 2021
4.3.8 Bayer Recent Developments
4.4 Johnson & Johnson.
4.4.1 Johnson & Johnson. Corporation Information
4.4.2 Johnson & Johnson. Description, Business Overview
4.4.3 Johnson & Johnson. Anticoagulants Products Offered
4.4.4 Johnson & Johnson. Anticoagulants Revenue and Gross Margin (2017-2022)
4.4.5 Johnson & Johnson. Anticoagulants Revenue by Product in 2021
4.4.6 Johnson & Johnson. Anticoagulants Revenue by Application in 2021
4.4.7 Johnson & Johnson. Anticoagulants Revenue by Geographic Area in 2021
4.4.8 Johnson & Johnson. Recent Developments
4.5 Genentech (Roche)
4.5.1 Genentech (Roche) Corporation Information
4.5.2 Genentech (Roche) Description, Business Overview
4.5.3 Genentech (Roche) Anticoagulants Products Offered
4.5.4 Genentech (Roche) Anticoagulants Revenue and Gross Margin (2017-2022)
4.5.5 Genentech (Roche) Anticoagulants Revenue by Product in 2021
4.5.6 Genentech (Roche) Anticoagulants Revenue by Application in 2021
4.5.7 Genentech (Roche) Anticoagulants Revenue by Geographic Area in 2021
4.5.8 Genentech (Roche) Recent Developments
4.6 Boehringer Ingelheim
4.6.1 Boehringer Ingelheim Corporation Information
4.6.2 Boehringer Ingelheim Description, Business Overview
4.6.3 Boehringer Ingelheim Anticoagulants Products Offered
4.6.4 Boehringer Ingelheim Anticoagulants Revenue and Gross Margin (2017-2022)
4.6.5 Boehringer Ingelheim Anticoagulants Revenue by Product in 2021
4.6.6 Boehringer Ingelheim Anticoagulants Revenue by Application in 2021
4.6.7 Boehringer Ingelheim Anticoagulants Revenue by Geographic Area in 2021
4.6.8 Boehringer Ingelheim Recent Development
4.7 Lilly
4.7.1 Lilly Corporation Information
4.7.2 Lilly Description, Business Overview
4.7.3 Lilly Anticoagulants Products Offered
4.7.4 Lilly Anticoagulants Revenue and Gross Margin (2017-2022)
4.7.5 Lilly Anticoagulants Revenue by Product in 2021
4.7.6 Lilly Anticoagulants Revenue by Application in 2021
4.7.7 Lilly Anticoagulants Revenue by Geographic Area in 2021
4.7.8 Lilly Recent Development
4.8 Daiichi Sankyo
4.8.1 Daiichi Sankyo Corporation Information
4.8.2 Daiichi Sankyo Description, Business Overview
4.8.3 Daiichi Sankyo Anticoagulants Products Offered
4.8.4 Daiichi Sankyo Anticoagulants Revenue and Gross Margin (2017-2022)
4.8.5 Daiichi Sankyo Anticoagulants Revenue by Product in 2021
4.8.6 Daiichi Sankyo Anticoagulants Revenue by Application in 2021
4.8.7 Daiichi Sankyo Anticoagulants Revenue by Geographic Area in 2021
4.8.8 Daiichi Sankyo Recent Development
4.9 Otsuka
4.9.1 Otsuka Corporation Information
4.9.2 Otsuka Description, Business Overview
4.9.3 Otsuka Anticoagulants Products Offered
4.9.4 Otsuka Anticoagulants Revenue and Gross Margin (2017-2022)
4.9.5 Otsuka Anticoagulants Revenue by Product in 2021
4.9.6 Otsuka Anticoagulants Revenue by Application in 2021
4.9.7 Otsuka Anticoagulants Revenue by Geographic Area in 2021
4.9.8 Otsuka Recent Development
4.10 AstraZeneca
4.10.1 AstraZeneca Corporation Information
4.10.2 AstraZeneca Description, Business Overview
4.10.3 AstraZeneca Anticoagulants Products Offered
4.10.4 AstraZeneca Anticoagulants Revenue and Gross Margin (2017-2022)
4.10.5 AstraZeneca Anticoagulants Revenue by Product in 2021
4.10.6 AstraZeneca Anticoagulants Revenue by Application in 2021
4.10.7 AstraZeneca Anticoagulants Revenue by Geographic Area in 2021
4.10.8 AstraZeneca Recent Development
4.11 Pfizer
4.11.1 Pfizer Corporation Information
4.11.2 Pfizer Description, Business Overview
4.11.3 Pfizer Anticoagulants Products Offered
4.11.4 Pfizer Anticoagulants Revenue and Gross Margin (2017-2022)
4.11.5 Pfizer Anticoagulants Revenue by Product in 2021
4.11.6 Pfizer Anticoagulants Revenue by Application in 2021
4.11.7 Pfizer Anticoagulants Revenue by Geographic Area in 2021
4.11.8 Pfizer Recent Development
4.12 Aspen
4.12.1 Aspen Corporation Information
4.12.2 Aspen Description, Business Overview
4.12.3 Aspen Anticoagulants Products Offered
4.12.4 Aspen Anticoagulants Revenue and Gross Margin (2017-2022)
4.12.5 Aspen Anticoagulants Revenue by Product in 2021
4.12.6 Aspen Anticoagulants Revenue by Application in 2021
4.12.7 Aspen Anticoagulants Revenue by Geographic Area in 2021
4.12.8 Aspen Recent Development
4.13 The Medicines Company
4.13.1 The Medicines Company Corporation Information
4.13.2 The Medicines Company Description, Business Overview
4.13.3 The Medicines Company Anticoagulants Products Offered
4.13.4 The Medicines Company Anticoagulants Revenue and Gross Margin (2017-2022)
4.13.5 The Medicines Company Anticoagulants Revenue by Product in 2021
4.13.6 The Medicines Company Anticoagulants Revenue by Application in 2021
4.13.7 The Medicines Company Anticoagulants Revenue by Geographic Area in 2021
4.13.8 The Medicines Company Recent Development
5 Breakdown Data by Type
5.1 Global Anticoagulants Revenue by Type (2017-2022)
5.2 Global Anticoagulants Revenue Forecast by Type (2023-2028)
5.3 Anticoagulants Revenue Marke Share by Type (2017-2028)
6 Breakdown Data by Application
6.1 Global Anticoagulants Revenue by Application (2017-2022)
6.2 Global Anticoagulants Revenue Forecast by Application (2023-2028)
6.3 Anticoagulants Revenue Market Share by Application (2017-2028)
7 North America
7.1 North America Anticoagulants Market Size YoY Growth 2017-2028
7.2 North America Anticoagulants Market Facts & Figures by Country (2017-2028)
7.3 North America Anticoagulants Revenue by Type (2017-2022)
7.4 North America Anticoagulants Revenue by Application (2017-2022)
8 Asia-Pacific
8.1 Asia-Pacific Anticoagulants Market Size YoY Growth 2017-2028
8.2 Asia-Pacific Anticoagulants Market Facts & Figures by Region (2017-2028)
8.3 Asia-Pacific Anticoagulants Revenue by Type (2017-2022)
8.4 Asia-Pacific Anticoagulants Revenue by Application (2017-2022)
9 Europe
9.1 Europe Anticoagulants Market Size YoY Growth 2017-2028
9.2 Europe Anticoagulants Market Facts & Figures by Country (2017-2028)
9.3 Europe Anticoagulants Revenue by Type (2017-2022)
9.4 Europe Anticoagulants Revenue by Application (2017-2022)
10 Latin America
10.1 Latin America Anticoagulants Market Size YoY Growth 2017-2028
10.2 Latin America Anticoagulants Market Facts & Figures by Country (2017-2028)
10.3 Latin America Anticoagulants Revenue by Type (2017-2022)
10.4 Latin America Anticoagulants Revenue by Application (2017-2022)
11 Middle East and Africa
11.1 Middle East and Africa Anticoagulants Market Size YoY Growth 2017-2028
11.2 Middle East and Africa Anticoagulants Market Facts & Figures by Country (2017-2028)
11.3 Middle East and Africa Anticoagulants Revenue by Type (2017-2022)
11.4 Middle East and Africa Anticoagulants Revenue by Application (2017-2022)
12 Supply Chain and Sales Channel Analysis
12.1 Anticoagulants Supply Chain Analysis
12.2 Anticoagulants Key Raw Materials and Upstream Suppliers
12.3 Anticoagulants Clients Analysis
12.4 Anticoagulants Sales Channel and Sales Model Analysis
12.4.1 Anticoagulants Distribution Channel Analysis: Indirect Sales VS Direct Sales
12.4.2 Anticoagulants Distribution Channel Analysis: Online Sales VS Offline Sales
12.4.3 Anticoagulants Distributors
13 Market Dynamics
13.1 Anticoagulants Industry Trends
13.2 Anticoagulants Market Drivers
13.3 Anticoagulants Market Challenges
13.4 Anticoagulants Market Restraints
14 Research Findings and Conclusion
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
List of Tables
Table 1. Global Anticoagulants Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028
Table 2. Major Companies of Platelet Aggregation Inhibitors (PAI)
Table 3. Major Companies of Low-Molecular-Weight Heparin (LMWH)
Table 4. Major Companies of Direct Thrombin Inhibitor (DTI)
Table 5. Major Companies of Direct Factor Xa Inhibitors (DFXa)
Table 6. Major Companies of Vitamin K antagonists (VKA)
Table 7. Major Companies of Others
Table 8. Global Anticoagulants Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028
Table 9. Global Anticoagulants Market Size by Region (US$ Million): 2022 VS 2028
Table 10. Global Anticoagulants Revenue by Region (2017-2022) & (US$ Million)
Table 11. Global Anticoagulants Revenue Forecast by Region (2023-2028) & (US$ Million)
Table 12. Anticoagulants Revenue by Company (2017-2022) & (US$ Million)
Table 13. Anticoagulants Revenue Share by Company (2017-2022)
Table 14. Ranking of Global Top Anticoagulants Players by Revenue (US$ Million) in 2021
Table 15. Global Anticoagulants Companies Market Concentration Ratio (CR5 and HHI) & (2017-2022)
Table 16. Global Anticoagulants by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Anticoagulants as of 2021)
Table 17. Global Anticoagulants Companies Headquarters
Table 18. Global Anticoagulants Companies Product & Service
Table 19. Date of International Companies Enter into Anticoagulants Market
Table 20. Global Anticoagulants Mergers & Acquisitions, Expansion Plans
Table 21. Sanofi Corporation Information
Table 22. Sanofi Description and Business Overview
Table 23. Sanofi Anticoagulants Revenue (US$ Million) and Gross Margin (2017-2022)
Table 24. Sanofi Anticoagulants Product
Table 25. Sanofi Anticoagulants Revenue Proportion of Anticoagulants by Product in 2021
Table 26. Sanofi Anticoagulants Revenue Proportion of Anticoagulants by Application in 2021
Table 27. Sanofi Anticoagulants Revenue Proportion of Anticoagulants by Geographic Area in 2021
Table 28. Sanofi Recent Development
Table 29. Bristol-Myers Squibb Corporation Information
Table 30. Bristol-Myers Squibb Description and Business Overview
Table 31. Bristol-Myers Squibb Anticoagulants Revenue (US$ Million) and Gross Margin (2017-2022)
Table 32. Bristol-Myers Squibb Anticoagulants Product
Table 33. Bristol-Myers Squibb Anticoagulants Revenue Proportion of Anticoagulants by Product in 2021
Table 34. Bristol-Myers Squibb Anticoagulants Revenue Proportion of Anticoagulants by Application in 2021
Table 35. Bristol-Myers Squibb Anticoagulants Revenue Proportion of Anticoagulants by Geographic Area in 2021
Table 36. Bristol-Myers Squibb Recent Development
Table 37. Bayer Corporation Information
Table 38. Bayer Description and Business Overview
Table 39. Bayer Anticoagulants Revenue (US$ Million) and Gross Margin (2017-2022)
Table 40. Bayer Anticoagulants Product
Table 41. Bayer Anticoagulants Revenue Proportion of Anticoagulants by Product in 2021
Table 42. Bayer Anticoagulants Revenue Proportion of Anticoagulants by Application in 2021
Table 43. Bayer Anticoagulants Revenue Proportion of Anticoagulants by Geographic Area in 2021
Table 44. Bayer Recent Development
Table 45. Johnson & Johnson. Corporation Information
Table 46. Johnson & Johnson. Description and Business Overview
Table 47. Johnson & Johnson. Anticoagulants Revenue (US$ Million) and Gross Margin (2017-2022)
Table 48. Johnson & Johnson. Anticoagulants Product
Table 49. Johnson & Johnson. Anticoagulants Revenue Proportion of Anticoagulants by Product in 2021
Table 50. Johnson & Johnson. Anticoagulants Revenue Proportion of Anticoagulants by Application in 2021
Table 51. Johnson & Johnson. Anticoagulants Revenue Proportion of Anticoagulants by Geographic Area in 2021
Table 52. Johnson & Johnson. Recent Development
Table 53. Genentech (Roche) Corporation Information
Table 54. Genentech (Roche) Description and Business Overview
Table 55. Genentech (Roche) Anticoagulants Revenue (US$ Million) and Gross Margin (2017-2022)
Table 56. Genentech (Roche) Anticoagulants Product
Table 57. Genentech (Roche) Anticoagulants Revenue Proportion of Anticoagulants by Product in 2021
Table 58. Genentech (Roche) Anticoagulants Revenue Proportion of Anticoagulants by Application in 2021
Table 59. Genentech (Roche) Anticoagulants Revenue Proportion of Anticoagulants by Geographic Area in 2021
Table 60. Genentech (Roche) Recent Development
Table 61. Boehringer Ingelheim Corporation Information
Table 62. Boehringer Ingelheim Description and Business Overview
Table 63. Boehringer Ingelheim Anticoagulants Revenue (US$ Million) and Gross Margin (2017-2022)
Table 64. Boehringer Ingelheim Anticoagulants Product
Table 65. Boehringer Ingelheim Anticoagulants Revenue Proportion of Anticoagulants by Product in 2021
Table 66. Boehringer Ingelheim Anticoagulants Revenue Proportion of Anticoagulants by Application in 2021
Table 67. Boehringer Ingelheim Anticoagulants Revenue Proportion of Anticoagulants by Geographic Area in 2021
Table 68. Lilly Corporation Information
Table 69. Lilly Description and Business Overview
Table 70. Lilly Anticoagulants Revenue (US$ Million) and Gross Margin (2017-2022)
Table 71. Lilly Anticoagulants Product
Table 72. Lilly Anticoagulants Revenue Proportion of Anticoagulants by Product in 2021
Table 73. Lilly Anticoagulants Revenue Proportion of Anticoagulants by Application in 2021
Table 74. Lilly Anticoagulants Revenue Proportion of Anticoagulants by Geographic Area in 2021
Table 75. Daiichi Sankyo Corporation Information
Table 76. Daiichi Sankyo Description and Business Overview
Table 77. Daiichi Sankyo Anticoagulants Revenue (US$ Million) and Gross Margin (2017-2022)
Table 78. Daiichi Sankyo Anticoagulants Product
Table 79. Daiichi Sankyo Anticoagulants Revenue Proportion of Anticoagulants by Product in 2021
Table 80. Daiichi Sankyo Anticoagulants Revenue Proportion of Anticoagulants by Application in 2021
Table 81. Daiichi Sankyo Anticoagulants Revenue Proportion of Anticoagulants by Geographic Area in 2021
Table 82. Otsuka Corporation Information
Table 83. Otsuka Description and Business Overview
Table 84. Otsuka Anticoagulants Revenue (US$ Million) and Gross Margin (2017-2022)
Table 85. Otsuka Anticoagulants Product
Table 86. Otsuka Anticoagulants Revenue Proportion of Anticoagulants by Product in 2021
Table 87. Otsuka Anticoagulants Revenue Proportion of Anticoagulants by Application in 2021
Table 88. Otsuka Anticoagulants Revenue Proportion of Anticoagulants by Geographic Area in 2021
Table 89. AstraZeneca Corporation Information
Table 90. AstraZeneca Description and Business Overview
Table 91. AstraZeneca Anticoagulants Revenue (US$ Million) and Gross Margin (2017-2022)
Table 92. AstraZeneca Anticoagulants Product
Table 93. AstraZeneca Anticoagulants Revenue Proportion of Anticoagulants by Product in 2021
Table 94. AstraZeneca Anticoagulants Revenue Proportion of Anticoagulants by Application in 2021
Table 95. AstraZeneca Anticoagulants Revenue Proportion of Anticoagulants by Geographic Area in 2021
Table 96. Pfizer Corporation Information
Table 97. Pfizer Description and Business Overview
Table 98. Pfizer Anticoagulants Revenue (US$ Million) and Gross Margin (2017-2022)
Table 99. Pfizer Anticoagulants Product
Table 100. Pfizer Anticoagulants Revenue Proportion of Anticoagulants by Product in 2021
Table 101. Pfizer Anticoagulants Revenue Proportion of Anticoagulants by Application in 2021
Table 102. Pfizer Anticoagulants Revenue Proportion of Anticoagulants by Geographic Area in 2021
Table 103. Aspen Corporation Information
Table 104. Aspen Description and Business Overview
Table 105. Aspen Anticoagulants Revenue (US$ Million) and Gross Margin (2017-2022)
Table 106. Aspen Anticoagulants Product
Table 107. Aspen Anticoagulants Revenue Proportion of Anticoagulants by Product in 2021
Table 108. Aspen Anticoagulants Revenue Proportion of Anticoagulants by Application in 2021
Table 109. Aspen Anticoagulants Revenue Proportion of Anticoagulants by Geographic Area in 2021
Table 110. The Medicines Company Corporation Information
Table 111. The Medicines Company Description and Business Overview
Table 112. The Medicines Company Anticoagulants Revenue (US$ Million) and Gross Margin (2017-2022)
Table 113. The Medicines Company Anticoagulants Product
Table 114. The Medicines Company Anticoagulants Revenue Proportion of Anticoagulants by Product in 2021
Table 115. The Medicines Company Anticoagulants Revenue Proportion of Anticoagulants by Application in 2021
Table 116. The Medicines Company Anticoagulants Revenue Proportion of Anticoagulants by Geographic Area in 2021
Table 117. Global Anticoagulants Revenue by Type (2017-2022) & (US$ Million)
Table 118. Global Anticoagulants Revenue by Application (2017-2022) & (US$ Million)
Table 119. Global Anticoagulants Revenue Forecast by Application (2023-2028) & (US$ Million)
Table 120. North America Anticoagulants Revenue by Country (2017-2022) & (US$ Million)
Table 121. North America Anticoagulants Revenue by Country (2023-2028) & (US$ Million)
Table 122. North America Anticoagulants Revenue by Type (2017-2022) & (US$ Million)
Table 123. North America Anticoagulants Revenue by Application (2017-2022) & (US$ Million)
Table 124. Asia-Pacific Anticoagulants Revenue by Region (2017-2028) & (US$ Million)
Table 125. Asia-Pacific Anticoagulants Revenue by Region (2023-2028) & (US$ Million)
Table 126. Asia-Pacific Anticoagulants Revenue by Type (2017-2022) & (US$ Million)
Table 127. Asia-Pacific Anticoagulants Revenue by Application (2017-2022) & (US$ Million)
Table 128. Europe Anticoagulants Revenue by Country (2017-2022) & (US$ Million)
Table 129. Europe Anticoagulants Revenue by Country (2023-2028) & (US$ Million)
Table 130. Europe Anticoagulants Revenue by Type (2017-2022) & (US$ Million)
Table 131. Europe Anticoagulants Revenue by Application (2017-2022) & (US$ Million)
Table 132. Latin America Anticoagulants Revenue by Country (2017-2022) & (US$ Million)
Table 133. Latin America Anticoagulants Revenue by Country (2023-2028) & (US$ Million)
Table 134. Latin America Anticoagulants Revenue by Type (2017-2022) & (US$ Million)
Table 135. Latin America Anticoagulants Revenue by Application (2017-2022) & (US$ Million)
Table 136. Middle East and Africa Anticoagulants Revenue by Country (2017-2022) & (US$ Million)
Table 137. Middle East and Africa Anticoagulants Revenue by Country (2023-2028) & (US$ Million)
Table 138. Middle East and Africa Anticoagulants Revenue by Type (2017-2022) & (US$ Million)
Table 139. Middle East and Africa Anticoagulants Revenue by Application (2017-2022) & (US$ Million)
Table 140. Anticoagulants Key Raw Materials, Industry Status and Trend
Table 141. Anticoagulants Key Raw Materials and Upstream Suppliers
Table 142. Anticoagulants Clients Status and Trend
Table 143. Anticoagulants Typical Clients
Table 144. Anticoagulants Distributors
Table 145. Anticoagulants Market Trends
Table 146. Anticoagulants Market Drivers
Table 147. Anticoagulants Market Challenges
Table 148. Anticoagulants Market Restraints
Table 149. Research Programs/Design for This Report
Table 150. Key Data Information from Secondary Sources
Table 151. Key Data Information from Primary Sources
List of Figures
Figure 1. Anticoagulants Product Picture
Figure 2. Global Anticoagulants Revenue Market Share by Type in 2021 & 2028
Figure 3. Platelet Aggregation Inhibitors (PAI) Product Picture
Figure 4. Low-Molecular-Weight Heparin (LMWH) Product Picture
Figure 5. Direct Thrombin Inhibitor (DTI) Product Picture
Figure 6. Direct Factor Xa Inhibitors (DFXa) Product Picture
Figure 7. Vitamin K antagonists (VKA) Product Picture
Figure 8. Others Product Picture
Figure 9. Global Anticoagulants Revenue Market Share by Application in 2021 & 2028
Figure 10. VTE
Figure 11. ACS/MI
Figure 12. AF
Figure 13. Others
Figure 14. Anticoagulants Report Years Considered
Figure 15. Global Anticoagulants Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 16. Global Anticoagulants Market Size 2017-2028 (US$ Million)
Figure 17. Global Anticoagulants Market Size Market Share by Region: 2022 Versus 2028
Figure 18. Global Anticoagulants Revenue Market Share by Region (2017-2028)
Figure 19. Anticoagulants Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2017 VS 2021
Figure 20. Global Anticoagulants Revenue Market Share Forecast by Type (2017-2028)
Figure 21. Global Anticoagulants Revenue Market Share Forecast by Application (2017-2028)
Figure 22. North America Anticoagulants Revenue 2017-2028 (US$ Million)
Figure 23. North America Anticoagulants Revenue Market Share by Type (2017-2022)
Figure 24. North America Anticoagulants Revenue Market Share by Application (2017-2022)
Figure 25. Asia-Pacific Anticoagulants Revenue 2017-2028 (US$ Million)
Figure 26. Asia-Pacific Anticoagulants Revenue Market Share by Region (2017-2028)
Figure 27. Asia-Pacific Anticoagulants Revenue Market Share by Type (2017-2022)
Figure 28. Asia-Pacific Anticoagulants Revenue Market Share by Application (2017-2022)
Figure 29. Europe Anticoagulants Revenue Growth Rate 2017-2028 (US$ Million)
Figure 30. Europe Anticoagulants Revenue Market Share by Country (2017-2028)
Figure 31. Europe Anticoagulants Revenue Market Share by Type (2017-2022)
Figure 32. Europe Anticoagulants Revenue Market Share by Application (2017-2022)
Figure 33. Latin America Anticoagulants Revenue Growth Rate 2017-2028 (US$ Million)
Figure 34. Latin America Anticoagulants Revenue Market Share by Country (2017-2022)
Figure 35. Latin America Anticoagulants Revenue Market Share by Type (2017-2022)
Figure 36. Latin America Anticoagulants Revenue Market Share by Application (2017-2022)
Figure 37. Middle East and Africa Anticoagulants Revenue Growth Rate 2017-2028 (US$ Million)
Figure 38. Middle East and Africa Anticoagulants Revenue Market Share by Country (2017-2028)
Figure 39. Middle East and Africa Anticoagulants Revenue Market Share by Type (2017-2022)
Figure 40. Middle East and Africa Anticoagulants Revenue Market Share by Application (2017-2022)
Figure 41. Anticoagulants Supply Chain (Upstream and Downstream Market)
Figure 42. Global Production Market Share of Anticoagulants Raw Materials by Region in 2021
Figure 43. Anticoagulants Distribution Channels
Figure 44. Global Anticoagulants Percentage 2017-2028: Indirect Sales VS Direct Sales
Figure 45. Global Anticoagulants Percentage 2017-2028: Online Sales VS Offline Sales
Figure 46. Bottom-up and Top-down Approaches for This Report
Figure 47. Data Triangulation
Figure 48. Key Executives Interviewed
  • Global Fibrinogen Concentrate Market Research Report 2024
    Published: 08-Jan-2024        Price: US 2900 Onwards        Pages: 84
    The Fibrinogen Concentrate market covers Human Fibrinogen Concentrate, Other, etc. The typical players include CSL Behring, LFB, Shanghai RAAS, Boya, Hualan Biological Engineering, etc. The global Fibrinogen Concentrate market was valued at US$ 796 million in 2023 and is anticipated to reach US$ 2207.6 million by 2030, witnessing a CAGR of 15.5% during The forecast period 2024-2030. The major producers in The industry are CSL Behring, LFB Group and Shanghai RAAS B......
  • Global Fibrinogen Concentrate Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 91
    According to our LPI (LP Information) latest study, the global Fibrinogen Concentrate market size was valued at US$ 778.7 million in 2023. With growing demand in downstream market, the Fibrinogen Concentrate is forecast to a readjusted size of US$ 2211.3 million by 2030 with a CAGR of 16.1% during review period. The research report highlights the growth potential of the global Fibrinogen Concentrate market. Fibrinogen Concentrate are expected to show stable growth in the future market. H......
  • Global Low Molecular Weight Heparin Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 04-Jan-2024        Price: US 3380 Onwards        Pages: 124
    Market Overview of Global Low Molecular Weight Heparin market: According to our latest research, the global Low Molecular Weight Heparin market looks promising in the next 5 years. As of 2022, the global Low Molecular Weight Heparin market was estimated at USD 359.23 million, and it's anticipated to reach USD 601.59 million in 2028, with a CAGR of 8.97% during the forecast years. Low-molecular-weight heparin (LMWH) is a class of anticoagulant medications. They are used in the......
  • Global Anticoagulants Market Growth (Status and Outlook) 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 106
    According to our LPI (LP Information) latest study, the global Anticoagulants market size was valued at US$ 25390 million in 2023. With growing demand in downstream market, the Anticoagulants is forecast to a readjusted size of US$ 35420 million by 2030 with a CAGR of 4.9% during review period. The research report highlights the growth potential of the global Anticoagulants market. Anticoagulants are expected to show stable growth in the future market. However, product differentiation, r......
  • Global Injectable Anticoagulants Market Growth (Status and Outlook) 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 95
    According to our LPI (LP Information) latest study, the global Injectable Anticoagulants market size was valued at US$ 5959.5 million in 2023. With growing demand in downstream market, the Injectable Anticoagulants is forecast to a readjusted size of US$ 6929.9 million by 2030 with a CAGR of 2.2% during review period. The research report highlights the growth potential of the global Injectable Anticoagulants market. Injectable Anticoagulants are expected to show stable growth in the futu......
  • Global Low Molecular Weight Heparin Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 88
    According to our LPI (LP Information) latest study, the global Low Molecular Weight Heparin market size was valued at US$ 331.2 million in 2023. With growing demand in downstream market, the Low Molecular Weight Heparin is forecast to a readjusted size of US$ 485.1 million by 2030 with a CAGR of 5.6% during review period. The research report highlights the growth potential of the global Low Molecular Weight Heparin market. Low Molecular Weight Heparin are expected to show stable growth i......
  • Global Heparin Sodium Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 132
    According to our LPI (LP Information) latest study, the global Heparin Sodium market size was valued at US$ 3301.4 million in 2023. With growing demand in downstream market, the Heparin Sodium is forecast to a readjusted size of US$ 5093.5 million by 2030 with a CAGR of 6.4% during review period. The research report highlights the growth potential of the global Heparin Sodium market. Heparin Sodium are expected to show stable growth in the future market. However, product differentiation,......
  • Global Intravenous Immunoglobulin (IVIg) Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 120
    According to our LPI (LP Information) latest study, the global Intravenous Immunoglobulin (IVIg) market size was valued at US$ 10090 million in 2023. With growing demand in downstream market, the Intravenous Immunoglobulin (IVIg) is forecast to a readjusted size of US$ 15290 million by 2030 with a CAGR of 6.1% during review period. The research report highlights the growth potential of the global Intravenous Immunoglobulin (IVIg) market. Intravenous Immunoglobulin (IVIg) are expected to ......
  • Global Heparin Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 128
    According to our LPI (LP Information) latest study, the global Heparin market size was valued at US$ 2286.2 million in 2023. With growing demand in downstream market, the Heparin is forecast to a readjusted size of US$ 3831.5 million by 2030 with a CAGR of 7.7% during review period. The research report highlights the growth potential of the global Heparin market. Heparin are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply ......
    • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs